NRx Pharmaceuticals Inc
NRXPW• NASDAQ
$0.01
-0.01-50.00%
In the past 24 hours
No 24-hour summary has been generated yet.
Financial highlights
Latest saved period: December 2025 · 2025-12-31
Revenue
$983.00K
Net income
$360.00K
Free cash flow
-$3.71M
Diluted EPS
—
Gross margin
48.32%
Profit margin
36.62%
Assets
$12.96M
Cash
$7.80M
Valuation
Market Cap$714.61M
Enterprise Value$0.00
PE (TTM)—
PE (Fwd)0.00
Price to Sales0.00
EV / EBITDA0.00
Price to Book0.00
PEG Ratio—
Cash Flow
FCF Yield-1.97%
FCF / Share-$0.44
SBC-Adj FCF Yield-2.01%
SBC-Adj FCF / Share-$0.45
SBC Impact+1.62%
Margins & Growth
Gross Margin47.10%
Operating Margin-1324.41%
Profit Margin-2328.97%
Quarterly Rev YoY+24475.00%
Quarterly EPS YoY+103.97%
Balance
Cash$7.80M
Debt$316.00K
Net Debt-$7.48M
Current Ratio0.31
Debt / Equity—
Dividend
Dividend Yield—
Payout Ratio—
DPS (TTM)$0.00
Last Ex-Date—
Dividend history
Cash dividends by ex-date, not an investment recommendation.
No saved cash dividend records are available for this instrument yet.
Price
-99.84%
Jul 19, 2021 - Apr 29, 2026 · 1,073 daily points
Revenue
↑ 470.6%Net Income
↑ 2540.0%Free Cash Flow
↓ 1316.8%Diluted EPS
No data
Quick Stats
Open
$0.01
Day High
$0.01
Day Low
$0.01
Prev Close
$0.01
Market Cap
—
Volume
56,012
NRx Pharmaceuticals Inc (NRXPW) analysis
Wrqti brings NRx Pharmaceuticals Inc data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Available price
$0.01
Market cap
$714.61M
PE ratio
—
Price to book
0.00
Profit margin
-2328.97%
FCF yield
-1.97%
Stocks related to NRx Pharmaceuticals Inc
Companies in the same sector you can compare with NRx Pharmaceuticals Inc: